BCAP31 and hepatocellular carcinoma: Anti-BAP31 antibody significantly suppressed the tumor formation of HCC cells in vivo compared with that in the IgG isotype and PBS control groups; thus, BAP31 may be a new therapeutic candidate for HCC treatment.